Life Sciences
Boston Biotech Rezera Says Its Pill Boosts Semaglutide's Anti-Inflammatory Effect
Rezera reported positive Phase 2 results on October 7, 2026 for ruvonoflast combined with semaglutide in 82 adults with obesity.
The Latest
Honk! Parade, Sorkin's 'Mockingbird' Headline Boston's Fall Arts Weekend
Cape Cod Weaver Puts $2,750 Price Tag On Leather Nantucket Baskets
BD Marks 65 Years In Canaan, Pours $34M Into Syringe Plant
Boston's Latitude Beverage Bets On $69.99 Bourbon In First Year-Round Launch
Marlborough Cleaning Firm Pushes Into Hartford, Providence Markets
New HospitalEncompass Health Opens 50-Bed Rehab Hospital In Bangor
1 min read
GroundbreakingDraper Breaks Ground On 111,000-Square-Foot Lowell Chip Plant
1 min read
City HallLawrence Council Delays No-Confidence Vote On Mayor DePena
Gone ViralBlackstone Ice Cream Shop Goes Viral After Backing Teen Worker
Housing DataSeacoast Home Listings Hit Multiyear High As Sales Cool
Expansion PlanLoon Mountain Pitches Fourth Peak On National Forest Land
New CEOAlexa's Architect Takes Over As Boston Dynamics CEO
1 min read
EventsThis Week in New England Business Events: Oct 7 to Oct 14
1 min read
InnovationHow a Maine Marketing Agency Built the Software That Runs Its Clients' Businesses
4 min read